文献速递术前评估与围术期医学区域麻醉与超声疼痛医学

全院多学科加速外科康复框架对围术期阿片类药物使用的影响:49,394例患者的回顾性队列研究

Impact of a Multidisciplinary Institution-Wide Enhanced Surgical Recovery Framework on Perioperative Opioid Use: A Retrospective Cohort Study of 49,394 Patients.
PubMed 文献 · Anesth Analg · 2026-10-07

本研究回顾性分析49,394例手术患者,比较加速外科康复(ESR)实施前2年与实施后10年间的阿片类药物使用情况。结果显示ESR实施与所有出院去向患者阿片类药物用量显著降低相关,且多模式镇痛使用率提高,而疼痛评分保持稳定。

要点

  • ESR实施后各出院组阿片用量均降低,POD≥2出院组降幅最大。
  • 多模式镇痛使用率在各出院组均提高,POD≥2组从70.6%升至89.0%。
  • ESR前后最大疼痛评分保持稳定,疼痛控制未受影响。

核心结论

  • 全院实施ESR框架与围术期阿片类药物用量降低相关,且不损害疼痛控制。

研究设计与样本

  • 回顾性队列分析,纳入49,394例患者(ESR前14,607例,ESR后34,787例),覆盖10年期间大型学术医疗中心的日间和住院手术。

主要发现

  • 分段回归分析显示阿片使用下降趋势始于ESR规划阶段,并在方案启动后进一步下降;ESR开始后所有出院组多模式镇痛显著增加。
  • ESR实施前后最大疼痛评分保持稳定。

临床怎么用

  • 在多学科框架下推广患者教育和多模式镇痛(包括区域麻醉和至少两种非阿片药物辅剂)以促进阿片节约。
  • 根据出院去向和具体方案定制多模式镇痛策略,同时保持标准化。

局限性

  • 回顾性队列设计,可能存在残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Enhanced surgical recovery (ESR) programs aim to support opioid-sparing care through patient education and multimodal analgesia (MMA) with pharmacologic and regional anesthesia approaches. Few studies have evaluated longitudinal, institution-wide ESR implementation across multiple surgical specialties. METHODS: We completed a retrospective cohort analysis of patients with eligible surgical procedures 2 years prior to ESR implementation (base) and after implementation (ESR) for ambulatory and inpatient surgeries at a large academic medical center, covering a 10-year span. Patients were grouped by discharge disposition (same day discharge, postoperative day [POD]. 1discharge, and POD ≥ 2 discharge) and by individual protocol. We examined the association between ESR adoption and use of MMA, opioid consumption, and patient-reported pain scores. Oral morphine equivalency (OME) was compared for periprocedural (inpatient OME per day) and post-discharge (total outpatient OME prescribed within 30 days) phases of care. Utilization of multimodal analgesia (MMA use), including specific procedural (regional blocks with local anesthesia or intrathecal morphine) and pharmacologic contributors (administration of at least two periprocedural non-opiate pain medication adjuncts), was also examined, in addition to maximum pain score. RESULTS: Among 49,394 patients (14,607 Base; 34,787 post-ESR), ESR implementation was associated with meaningful reductions in opioid use for all discharge dispositions, with the most significant decreases observed among patients having surgery associated with longer postoperative stays (median [IQR], POD ≥ 2 discharge: Inpatient OME per day: Base 50.5 [27.3-83.7], ESR 36.3 [20.0-60.5], P < .0001; total outpatient OME: Base 300.0 [150.0-600.0], ESR 150.0 [90.0-225.0], P < .0001)). Utilization of non-opioid analgesics and regional analgesia varied by discharge disposition but was consistently observed to increase for ESR patients, with largest gains shown in the POD ≥ 2 discharge group (MMA use: same day discharge, base 50.1%, ESR 61.5%, P < .0001; POD 1 discharge, base 77.4%, ESR 89.1%, P < .0001; POD ≥2 discharge, base 70.6%, ESR 89.0%, P < .0001). Segmented regression analyses identified downward trends in opiate use beginning during the planning phase of ESR with additional decreases temporally aligned with protocol initiation. The models showed significantly increased MMA in all discharge groups since the start of ESR. Maximum pain scores before and after ESR implementation remained stable. CONCLUSIONS: System-wide implementation of an ESR framework was associated with lower perioperative opioid use without compromising pain control. Variation in MMA approach across individual protocols and discharge disposition groups highlights the value of multidisciplinary ESR programs in promoting effective and standardized, yet also customized, perioperative pain management practices.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Whalen AA, Brethauer SA, Halm K, et al. Impact of a Multidisciplinary Institution-Wide Enhanced Surgical Recovery Framework on Perioperative Opioid Use: A Retrospective Cohort Study of 49,394 Patients. Anesth Analg. 2026. PMID: 42847968. doi:10.1213/ANE.0000000000008097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。